|Bid||2.3400 x 2200|
|Ask||2.3500 x 4000|
|Day's Range||2.2300 - 2.4200|
|52 Week Range||2.0300 - 7.5000|
|Beta (5Y Monthly)||-0.54|
|PE Ratio (TTM)||N/A|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||N/A|
Evofem Biosciences, Inc. (NASDAQ: EVFM) today announced that its virtual fireside chat at the 2020 Cantor Global Virtual Healthcare Conference will take place from 1:20 p.m. to 1:50 p.m. ET on Thursday, September 17, 2020. This is an adjustment from the previously announced date and time.
Evofem Biosciences, Inc. (NASDAQ: EVFM) today announced pivotal results from the Phase 2b AMPREVENCE trial in a poster presentation from the 2020 STD Prevention Virtual Conference, which will take place online September 14 through 24.
Evofem Biosciences, Inc. (NASDAQ: EVFM), a commercial-stage biopharmaceutical company, today announced it will participate in four healthcare equity conferences in September: